Endogenous anti-inflammatory response after coronary injury in a porcine model

European Journal of Clinical Investigation

Volumn 31, Issue 12, 2001, Pages 1019-1023

  Fantidis, Panayotis ^a   Perez De Prada T ^a   Fernandez Ortiz A ^a   Sanmartin M ^a   Alfonso, F ^a   Hernandez R ^a   Escaned, J ^a   Banuelos C ^a   Sabate M ^a   Macaya, C ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Coronary artery; HPA axis; Vessel injury

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP; HYDROCORTISONE; INTERLEUKIN 1BETA;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHERECTOMY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORTICOTROPIN BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; HYDROCORTISONE BLOOD LEVEL; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEUKOCYTE; MULTIVARIATE ANALYSIS OF VARIANCE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SWINE;

ADRENOCORTICOTROPIC HORMONE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; CORONARY VESSELS; CORTICOTROPIN-RELEASING HORMONE; CYCLIC AMP; DISEASE MODELS, ANIMAL; HYDROCORTISONE; INTERLEUKIN-1; LEUKOCYTES; SWINE;

EID: 0035791521     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2001.00904.x     Document Type: Article

References (31)

1. Casadevall M, Saperas E, Panés J, Salas A, Anderson DC, Malagelada JR et al. Mechanisms underlying the anti-inflamatory actions of central corticotropin-releasing factor. Am J Physiol 1999;276:G1016-G1026.
2. Chrousos G. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995;332:1351-62.
3. Karalis K, Sano H, Redwine J, Listwak S, Wilder RI, Chrousos GP. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 1991;254:421-3.
4. Smith EM, Morrill AC, Meyer WJ, Blalock JE. Corticotropin releasing factor induction of leukocyte derived immunoreactive ACTH and endorphins. Nature 1986;321:881-2.
5. Singh VK, Leu SJ. Corticotropin-releasing factor-induced production of cyclic AMP by human peripheral blood immunocytes. Immunol Lett 1993;35:239-45.
6. Smith EM, Brosnan P, Meyer WJ, Blalock JE. An ACTH receptor on human mononuclear leucocytes. Relation to adrenal ACTH-receptor activity. N Engl J Med 1987;317:1266-9.
7. Johnson EW, Blalock JE, Smith EM. ACTH receptor-mediated induction of leucocyte cyclic AMP. Biochem Biophys Res Comm 1988;157:1205-11.
8. Ross R. Atherosclerosis-an inflammation disease. N Engl J Med 1999;340:115-26.
9. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-9.
10. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992;326:242-50.
11. Andersen HR, Maeng M, Thorwest M, Falk E. Remodeling rather than neointimal formation explains luminal narrowing after deep vessel wall injury. Insights from a porcine coronary (Re) stenosis model. Circulation 1996;93:1716-24.
12. Suzuki T, Ishiwata S, Hasegawa K, Yamamoto K, Yamazaki T. Raised interleukin 6 concentrations as a predictor of postangioplasty restenosis. Heart 2000;83:578.
13. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000;148:209-14.
14. Hojo Y, Ikeda U, Mizuno O, Fukazawa H, Kurosaki H, Fujikawa H et al. Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis. Heart 2000;84:83-7.
15. Srivasta S, Fitzpatrick LA, Tsao PW, Reilly TM, Holmes DR Jr, Schwartz RS et al. Selective ávß3 integrin blockade potently limits neointimal hyperplasia and lumen stenosis following deep coronary arterial stent injury: evidence for the functional importance of integrin ávß3 and osteroporin expression during neointima formation. Cardiovasc Res 1997;36:408-28.
16. Chamberlaín J, Gunn J, Francis S, Holt C, Crossman D. Temporal and spatial distribution of intreleukin-1 beta in bollon injured porcine coronary arteries. Cardiovasc Res 1999;44:156-65.
17. Fantuzzi G, Ku G, Harding MW, Livingston DL, Sipe JD, Kuida K et al. Response to local inflammation of IL-β converting enzyme-deficient mice. J Immunol 1997;158:1818-24.
18. Liao F, Andalibi A, de Beer FC, Fogelman AM, Lusis AJ. Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to atherogenic diet n mice. J Clin Invest 1993;90:2572-918.
19. Malagoli D, Franchini A, Ottaviani E. Synergistic role of cAMP and IP (3) in corticotropin- releasing hormone-induced cell shape changes in invertebrate immunocytes. Peptides 2000;21:175-82.
20. Liu L, Matthews SG. Adrenocortical response profiles to corticotrophin releasing hormone and adrenocorticotrophin challenge in the chronically catheterized adult guinea-pig. Exper Physiol 1999;84:971-7.
21. Masi AT, Chrousos GP. Hypothalamic-pituitary-adrenal-glucocorticoid axis function in rheumatoid arthritis. J Rheumatol 1996;23:577-81.
22. Pinsky D, Liao OH, Morris S, Brett J, Scacca R, Karakurum M et al. Restoration of the cAMP second messenger pathway enhances cardiac preservation for transplantation in a heterotopic rat model. J Clin Invest 1993;92:2994-3002.
23. Archipoff G, Beretz A, Froger-León C, De la Salle C, Klein-Soyer C, Cazenave JP I. Opposite regulation by cyclic AMP of thrombomodulin and tissue factor activities on the surface of human saphenous vein and endothelial cells in culture. Thromb Haemostasis 1991;65:349(Abstract).
24. Hoek J. Intracellular signal transduction and the control of endothelial permeability. Laboratory Invest 1992;67:1-4.
25. Ogawa S, Koga S, Kuwabara K, Morrow S, Morris J, Bilezikian S et al. Hypoxia-indiced increased permeability of endothelial monolayers occurs through lowering of cellular cAMP levels. Am J Physiol 1992;262:C546-C554.
26. 4 triggers remodelling of the cardiovascular sytem at birth. Nature 1997;390:78-81.
27. Biro S, Yu ZX, Fu YM, Smale G, Sasse S, Sanchez J et al. Expression and subcellular distribution of basic fibroblast growth factor are regulated during migration of endothelial cells. Cir Res 1994;74:485-94.
28. Larson DM, Haudenschild CC. Junctional transfer in wounded cultures of bovine aortic endothelial cells. Laboratory Invest 1988;59:373-9.
29. Caterina MJ, Devreotes PN. Molecular insights into eukaryotic chemotaxis. FASEB J 1991;5:3078-85.
30. Liuzzo G, Buffon A, Biasucci LM, Gallimore R, Caligiuri G, Vitelli A et al. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation 1998;98:2370-6.
31. Moreno PR, Falk E, Palacios IF, Newel JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndrome: implications for plaque rupture. Circulation 1994;90:775-8.